Fevig; John M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fevig; John M..The latest application filed is for "[6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists".

Company Profile

0.23.19

Fevig; John M. - Doylestown PA
Fevig; John M. - Lincoln University PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists Grant 8,513,265 - Fevig , et al. August 20, 2	2013-08-20
[6,5]--bicyclic GPR119 G protein-coupled receptor agonists Grant 8,476,283 - Fevig , et al. July 2, 2	2013-07-02
[6,6] And [6,7]-bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20130116237 - Fevig; John M. ; et al.	2013-05-09
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists Grant 8,314,095 - Fevig , et al. November 20, 2	2012-11-20
[6,6] And [6,7]-bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20120202790 - Fevig; John M. ; et al.	2012-08-09
[6,5] - Bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20120077826 - Fevig; John M. ; et al.	2012-03-29
[6,5]-bicyclic GPR119 G protein-coupled receptor agonists Grant 8,093,257 - Fevig , et al. January 10, 2	2012-01-10
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists Grant 8,076,322 - Fevig , et al. December 13, 2	2011-12-13
[6,6] And [6,7]-bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20110136783 - Fevig; John M. ; et al.	2011-06-09
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists Grant 7,910,583 - Fevig , et al. March 22, 2	2011-03-22
7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods Grant 7,723,355 - Fevig , et al. May 25, 2	2010-05-25
Pyrrolo(oxo)quinolines as 5HT ligands Grant 7,618,980 - Fevig , et al. November 17, 2	2009-11-17
Pyrrolo(oxo)isoquinolines as 5HT ligands Grant 7,572,805 - Fevig , et al. August 11, 2	2009-08-11
7,8-dihydro-1,6-naphthyridin-5(6h)-ones And Related Bicyclic Compounds As Inhibitors Of Dipeptidyl Peptidase Iv And Methods App 20090149492 - Fevig; John M. ; et al.	2009-06-11
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods Grant 7,521,557 - Devasthale , et al. April 21, 2	2009-04-21
[6,5]-bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20090018055 - Fevig; John M. ; et al.	2009-01-15
[6,6] And [6,7]-bicyclic Gpr119 G Protein-coupled Receptor Agonists App 20080293690 - Fevig; John M. ; et al.	2008-11-27
Guanidine mimics as factor Xa inhibitors Grant 7,235,575 - Lam , et al. June 26, 2	2007-06-26
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods App 20060264457 - Devasthale; Pratik ; et al.	2006-11-23
Novel guanidine mimics as factor Xa inhibitors App 20060040973 - Lam; Patrick Y. ; et al.	2006-02-23
Pyrrolo(oxo)isoquinolines as 5HT ligands App 20060014777 - Fevig; John M. ; et al.	2006-01-19
Pyrrolo(oxo)quinolines as 5HT ligands App 20060014778 - Fevig; John M. ; et al.	2006-01-19
Guanidine mimics factor Xa inhibitors Grant 6,958,356 - Lam , et al. October 25, 2	2005-10-25
Guanidine mimics as factor Xa inhibitors Grant 6,906,070 - Lam , et al. June 14, 2	2005-06-14
Nitrogen containing heterobicycles as factor Xa inhibitors Grant 6,858,616 - Fevig , et al. February 22, 2	2005-02-22
Substituted pyridoindoles as serotonin agonists and antagonists Grant 6,849,619 - Robichaud , et al. February 1, 2	2005-02-01
Substituted pyridoindoles as serotonin agonists and antagonists App 20040186094 - Robichaud, Albert J. ; et al.	2004-09-23
Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists Grant 6,777,406 - Fevig , et al. August 17, 2	2004-08-17
Substituted Pyrroloquinolines And Pyridoquinolines As Serotonin Agonists And Antagonists App 20040092502 - Fevig, John M. ; et al.	2004-05-13
Substituted pyridoindoles as serotonin agonists and antagonists Grant 6,699,852 - Robichaud , et al. March 2, 2	2004-03-02
Thrombin or factor Xa inhibitors Grant 6,602,871 - Lam , et al. August 5, 2	2003-08-05
Inhibitors of factor Xa with a neutral P1 specificity group Grant 6,602,895 - Galemmo, Jr. , et al. August 5, 2	2003-08-05
Inhibitors of factor Xa with a neutral P1 specificity group App 20030092740 - Galemmo, Robert A. ; et al.	2003-05-15
Nitrogen containing heterobicycles as factor Xa inhibitors App 20030069237 - Fevig, John M. ; et al.	2003-04-10
Novel guanidine mimics factor Xa inhibitors App 20030069258 - Lam, Patrick Y. ; et al.	2003-04-10
Substituted pyridoindoles as serotonin agonists and antagonists App 20020173503 - Robichaud, Albert ; et al.	2002-11-21
Thrombin or factor Xa inhibitors App 20020115854 - Lam, Patrick Y.S. ; et al.	2002-08-22
Nitrogen containing heterobicycles as factor Xa inhibitors Grant 6,413,980 - Fevig , et al. July 2, 2	2002-07-02
Novel guanidine mimics as factor Xa inhibitors App 20020025963 - Lam, Patrick Y. ; et al.	2002-02-28
Guanidine mimics as factor Xa inhibitors Grant 6,339,099 - Lam , et al. January 15, 2	2002-01-15
Inhibitors of factor Xa with a neutral P1 specificity group Grant 5,998,424 - Galemmo, Jr. , et al. December 7, 1	1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.